In a filing, SpringWorks Therapeutics Inc revealed its Chief Operating Officer Edris Badreddin unloaded Company’s shares for reported $0.84 million on Dec 03 ’24. In the deal valued at $41.97 per share,20,000 shares were sold. As a result of this transaction, Edris Badreddin now holds 209,600 shares worth roughly $8.0 million.
Then, Islam Saqib sold 49,000 shares, generating $2,027,357 in total proceeds. Upon selling the shares at $41.37, the Chief Executive Officer now owns 1,014,368 shares.
Before that, Islam Saqib sold 49,000 shares. SpringWorks Therapeutics Inc shares valued at $1,988,033 were divested by the Chief Executive Officer at a price of $40.57 per share. As a result of the transaction, Islam Saqib now holds 1,063,368 shares, worth roughly $40.61 million.
Evercore ISI initiated its SpringWorks Therapeutics Inc [SWTX] rating to an Outperform in a research note published on November 20, 2024; the price target was $60. A number of analysts have revised their coverage, including Guggenheim’s analysts, who began to cover the stock in early February with a ‘”a Buy”‘ rating. BofA Securities began covering SWTX with “Buy” recommendation on December 01, 2022. H.C. Wainwright maintained its rating on January 19, 2021. It rated SWTX as “a Buy”.
Price Performance Review of SWTX
On Friday, SpringWorks Therapeutics Inc [NASDAQ:SWTX] saw its stock jump 5.85% to $38.19. Over the last five days, the stock has gained 2.83%. SpringWorks Therapeutics Inc shares have risen nearly 5.70% since the year began. Nevertheless, the stocks have fallen -0.96% over the past one year. While a 52-week high of $53.92 was reached on 01/03/25, a 52-week low of $28.21 was recorded on 01/02/25. SMA at 50 days reached $36.22, while 200 days put it at $38.52.
Levels Of Support And Resistance For SWTX Stock
The 24-hour chart illustrates a support level at 36.68, which if violated will result in even more drops to 35.16. On the upside, there is a resistance level at 39.14. A further resistance level may holdings at 40.08. The Relative Strength Index (RSI) on the 14-day chart is 54.19, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.03, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 17.53%. Stochastics %K at 44.95% indicates the stock is a holding.
How much short interest is there in SpringWorks Therapeutics Inc?
A steep rise in short interest was recorded in SpringWorks Therapeutics Inc stocks on 2024-12-13, dropping by -0.6 million shares to a total of 11.69 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 12.29 million shares. There was a decline of -5.11%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on October 29, 2020 when H.C. Wainwright resumed its ‘”a Buy”‘ rating for the stock and retained the price target to $73.